Pacira | PCRX - Action





Action Changement Date
Astellas Pharma JPY 331.01B 33.75B 2026-03
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Cara Therapeutics USD 900K 0 2025-03
Coherus Biosciences USD 5.67M 842K 2026-06
Heron Therapeutics USD 54.57M 2.33M 2022-12
J&J USD 15.14B 561M 2026-06
Ligand Pharmaceuticals USD 10.26M 3M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novo Nordisk DKK 45.65B 21.26B 2025-06
Omeros USD 712K 266K 2021-09
Pacira USD 134.57M 15.8M 2026-06
Perrigo USD 1.06B 56.9M 2026-06
Pfizer USD 9.94B 722M 2026-06
Supernus Pharmaceuticals USD 107.03M 3.74M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Xeris Pharmaceuticals USD 80.93M 6.7M 2026-06
Zoetis USD 2.57B 24M 2026-06